Special Update on Alzheimer’s Drugs Leqembi (lecanemab) and Kisunla (donanemab)
Expanded Approvals for Dupixent, Keytruda, Mavyret, Nucala, Susvimo; New Meds: Widaplik for High Blood Pressure, Yeztugo for HIV prevention
June 2025 Safety Update Part 2: Warnings for Transderm Scop, Caprelsa, Hyzaar, Xarelto, GLP-1s (Mounjaro and more)
June 2025 Drug Safety Update: Recalls of Carvedilol, Zicam Nasal Swabs, Generic Bactrim; New Warnings for Depakote and Lamictal; GLP-1 meds and Eye Disease (wet AMD)
Nationwide eye drops recall; New lung, liver, ovarian cancer drugs; Gene therapy trial tragedy; new migraine injectable; Allergy med tips; Fish oil supplement good news; more
May 2025 Safety Update Part 2: Spravato Antidepressant, Clozapine, Ambrisentan, Korean Sunscreens, Children's Claritin, "Gas Station Heroin," Fluoride Tablets, Medication Tips
May 2025 Safety Update: Duloxetine Recall; New Warnings for Gabapentin, Lyrica, Doxycycline, Other Antibiotics; Animal Testing Changes; FDA Delays Continue; Medication Tips
Phase-out of Animal Studies Requirement for Investigational New Drug Applications
FDA Delays Some Updates; Product Warnings for Topical Hair Loss Treatment; Supplements with Hidden Ingredients; Counterfeit Ozempic
April 2025 Drug Safety: Lidocaine cream; new side effects for migraine drugs; antidepressants study; Pluvicto for prostate cancer; Imfinzi; Tymlos; vitamin B-12 quality; microplastics in teabags
March 2025 Drug Safety Part 2: New warnings for MRI contrast agents; Baqsimi, Belsomra, Furoscix, Iluvien ophthalmic, Metronidazole; Recalls of ADHD and acne meds; medication tips
March 2025 Drug Safety Updates Part 1: Cardiac Risk Warning Removed for Testosterone Meds; News for Bactrim, Lybalvi, Nplate, Prolensa, Remicade, TNKase
Drug and Device Approvals: Deep Brain Stimulation Therapy for PD; generic Xarelto; neffy nasal epinephrine spray; Odactra for dust mite allergies; Encelto for rare eye disease
February 2025 Part 3 Drug Safety News: Geodon; Paxlovid; Ozempic shortage ends; blood thinners and A-Fib; drug-induced high blood pressure; REMS news; podcast recommendation
February 2025 Drug Safety Part 2: FDA REMS news; Abilify; Isoniazid; Ongentys for Parkinson's; Osphena for menopause
February 2025 Drug Safety Updates Part 1: Enhertu, Omvoh, Ozempic expanded approvals and new warnings; MS drug's new boxed warning; glaucoma eye drops and corneal swelling; Xtandi choking risk; more
New Formulations for Popular Meds; Nicotine and Health Risks; Generic Facility Warned; Anti-Aging Emerging Therapies and Hype; More
January 2025 Part 1: Safety warning for RSV vaccines; Depo Provera contraceptive link to brain tumors; iron infusion therapy risk; Ozempic and rare eye condition; Gemtesa for overactive bladder; more
